• SENSEX 81,451.01
    -182.01 (--0.22%)
  • BANKNIFTY 55,749.70
    203.65 (+0.37%)
  • Suzlon Energy
    74.30 86.04(%)
  • Reliance Power
    60.50 60.50(%)
  • Swiggy
    338.00 617.00(%)
  • Mazagon Dock
    3,450.00 1,200.00(%)
  • Eternal Ltd
    243.00 304.50(%)
  • MMTC
    88.20 131.88(%)
  • Garden Reach Sh.
    2,926.85 1,148.10(%)
  • Waaree Energies
    2,956.60 1,808.65(%)
  • Indian Energy Ex
    203.20 244.35(%)
  • Bharat Dynamics
    2,096.00 2,096.00(%)
  • Engineers India
    239.00 304.00(%)
  • NBCC
    126.41 139.83(%)
  • IFCI
    66.71 35.67(%)
  • Muthoot Finance
    2,241.75 2,444.65(%)
  • HDFC Bank
    1,948.60 1,977.95(%)
  • LMW
    16,640.85 13,456.85(%)
  • Hind.Aeronautics
    4,962.00 3,045.95(%)
  • Pidilite Inds.
    3,127.25 3,414.40(%)
  • Infosys
    1,555.10 1,307.10(%)
  • Ola Electric
    48.07 45.55(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Laurus Labs Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 45955.0
  • ISIN : INE947Q01028
609.60 -5 (-0.80%)
  • As on 31 May 2025 (EOD)

  • Today’s Low

    606.50

  • Today’s High

    618.50

  • Open

    615.00

  • Perv Close

    614.50

  • 52W Low

    385.45

  • 52W High

    660.90

Key Indicators

  • P/E(TTM)

    86.40

  • Mar.Cap (₹Cr.)

    32,872.83

  • Div & Yield %

    0.13

  • Book Value(₹)

    84.63

  • Debt-Equity Ratio

    -0.80

  • AGM Date

    30-May-2025

  • EPS

    7.05

  • P/E Ratio

    86.40

Financials Ratios

  • Debt-Equity Ratio

    0.56

  • Mar.Cap (₹Cr.)

    32,872.83

  • RONW (%)

    4.13

  • ROCE (%)

    6.31

Score Board

  • Equity (₹ in Cr.)

    107.85

  • BV (₹)

    84.60

  • Sales( ₹ in Cr.)

    5,216.98

  • NP (in Cr.)

    380.39

  • NP Var(%)

    70.0

  • Div%

    40.0

  • CPS (₹)

    13.70

  • EPS (₹)

    7.10

  • Traded Value (₹ in Lakhs)

    32,845.87

  • 52 Week High

    660.90

  • 52 Week Low

    385.45

  • Price BSE

    609.0

  • Price NSE

    610.00

  • Market Capital( in Cr.)

    32,845.87

  • P/C Ratio

    44.40

  • P/E Ratio

    86.30

  • Price Vs.BV

    7.10

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 4,812.39 5,773.45 4,707.04 4,768.72 2,797.34 2,236.15
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 4,812.39 5,773.45 4,707.04 4,768.72 2,797.34 2,236.15
Other Income 47.42 15.95 21.55 27.32 5.81 16.13
Stock Adjustments 102.48 -40.82 218.62 296.45 218.09 28.92
Total Income 4,962.29 5,748.58 4,947.21 5,092.49 3,021.24 2,281.20
EXPENDITURE :            
Raw Materials 2,507.87 2,671.65 2,427.18 2,471.58 1,620.64 1,237.85
Power and Fuel Cost 309.67 301.10 188.52 149.69 132.62 105.50
Employee Cost 531.93 477.88 417.57 364.83 299.90 256.85
Other Manufacturing Expenses 491.94 431.99 326.34 298.12 191.38 151.49
Selling and Administration Expenses 293.96 323.95 265.52 260.60 190.04 145.00
Miscellaneous Expenses 29.62 44.30 15.33 10.48 10.62 16.92
Employee Benefit Expenses 531.93 477.88 417.57 364.83 299.90 256.85
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 4,164.99 4,250.87 3,640.46 3,555.30 2,445.20 1,913.61
Operating Profit 797.30 1,497.71 1,306.75 1,537.19 576.04 367.58
Interest 150.82 145.70 95.86 65.92 87.71 85.83
Gross Profit 646.48 1,352.01 1,210.89 1,471.27 488.33 281.75
Depreciation 345.01 300.58 235.48 196.64 183.85 160.53
Profit Before Tax 301.47 1,051.43 975.41 1,274.63 304.48 121.22
Current Tax 87.94 270.78 231.42 334.98 53.00 24.83
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -10.17 20.27 -6.10 -16.46 -15.57 1.39
Reported Net Profit 223.70 760.38 750.09 956.11 267.05 94.99
Extraordinary Items -0.57 -0.14 -0.85 -0.63 -0.67 -0.62
Adjusted Net Profit 224.27 760.52 750.94 956.74 267.72 95.61
Adjustment below Net Profit 0.00 0.00 0.00 0.00 -3.50 -3.27
P & L Balance brought forward 3,230.09 2,577.18 1,912.95 1,031.88 803.63 727.81
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 86.18 107.47 85.86 75.04 35.30 15.90
P & L Balance carried down 3,367.61 3,230.09 2,577.18 1,912.95 1,031.88 803.63
Dividend 86.18 107.47 85.86 75.04 16.04 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 40.00 100.00 100.00 100.00 25.00 15.00
Dividend Per Share(Rs) 0.80 2.00 2.00 2.00 2.50 1.50
Earnings Per Share-Unit Curr 4.15 14.12 13.96 17.82 24.98 8.92
Earnings Per Share(Adj)-Unit Curr 4.15 14.12 13.96 17.82 5.00 1.78
Book Value 78.06 75.31 63.05 50.54 169.84 149.47
Book Value(Adj)-Unit Curr 78.06 75.31 63.05 50.54 33.97 29.89

Shareholding Pattern

  • Promoter Group

    27.62%

  • Public Share Holding

    72.38%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 130,831,740 24.26 130,831,740 2
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 18,129,976 3.36 18,129,976 14
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 148,961,716 27.62 148,961,716 16
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 1,296 0.00 1,296 1
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 11 0.00 11 1
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 137,600,656 25.52 137,600,656 198
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 19,573,280 3.63 19,573,280 9
Mutual Funds / UTI 37,085,110 6.88 37,085,110 29
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 6,830,204 1.27 6,830,204 21
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 201,090,557 37.29 201,090,557 259
2] Non Institution
Bodies Corporate 44,520,610 8.26 44,520,610 1,450
Clearing Members 1,164 0.00 1,164 7
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 10,771,196 2.00 10,771,196 6,089
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 2,571,269 0.48 2,571,269 3,720
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 49,841,765 9.24 49,841,765 102
Individuals holding nominal share capital up to Rs. 1 lakh 77,667,381 14.40 77,667,381 281,252
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 3,824,908 0.71 3,824,908 9
Others 1,925 0.00 1,925 1
Sub Total 189,200,218 35.09 189,200,218 292,630
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 539,252,491 100.00 539,252,491 292,905

Company Background

Laurus Labs LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Laurus Labs Ltd
  • BSE Code : 45955.0
  • ISIN : INE947Q01028

  • Incorporation Year

    2005

  • Registered Office

    Plot No 21 Jawaharlal Nehru
    Pharma City Parawada, Visakhapatnam,
    Andhra Pradesh-531021

  • Telephone

    91-891-3061222

  • FAX

    91-891-3061270

  • Chairman

    Ravindranath Kancherla

  • Managing Director

  • Company Secretary

    G Venkateswar Reddy

  • Auditor

    Deloitte Haskins & Sells LLP

  • Face Value

    2

  • Listing

    NSE

  • Registrar

    KFin Techologies Ltd
    Karvy Selenium Tow-B,
    31&32 Financial Dist,Nanakramguda
    Mumbai - Hyderabad-500032

Laurus Labs Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Laurus Labs 609.10 4,859.81 4,812.39 86.40 7.34
Abbott India 30,453.15 6,097.18 5,848.91 45.75 44.71
Astrazeneca Phar 7,965.20 1,330.33 1,295.53 205.34 33.26
P & G Health Ltd 5,775.85 1,166.89 1,151.26 40.53 39.76
Glaxosmi. Pharma 3,295.00 3,530.73 3,407.25 60.74 44.44
Cipla 1,464.85 17,645.00 16,574.34 22.94 20.10
Amrutanjan Healt 711.95 437.58 421.23 40.50 20.84
Fermenta Biotec. 311.95 315.24 307.09 13.58 4.10
Guj. Themis Bio. 307.95 174.19 169.82 68.74 44.82
Bliss GVS Pharma 131.10 638.96 605.46 20.02 11.19
Ambalal Sarabhai 37.87 11.70 3.81 16.18 1.92